Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Unconventional T-lymphocyte populations are increasingly recognized for their role in tumor immunity.
• The specific function of innate alpha-beta T cells (iαβT) in pancreatic ductal adenocarcinoma (PDA) remains largely unexplored.

Purpose of the Study:

• To investigate the role and therapeutic potential of innate alpha-beta T cells (iαβT) in pancreatic ductal adenocarcinoma (PDA).

Main Methods:

• Analysis of T-lymphocyte populations in murine and human PDA models.
• Characterization of intratumoral iαβT phenotype and T-cell receptor repertoire.
• Assessment of iαβT-cell adoptive transfer efficacy.
• Investigation of iαβT-mediated macrophage reprogramming via CCR5 signaling.

Main Results:

• iαβTs constitute approximately 10% of T lymphocytes in PDA, exhibiting a distinct, immunogenic phenotype.
• Intratumoral iαβTs are a major source of IL17, comprising ~75% of IL17+ cells.
• Adoptive transfer of iαβTs demonstrated protective effects in PDA models.
• iαβTs induce CCR5-dependent reprogramming of tumor-associated macrophages, promoting CD4+ and CD8+ T-cell expansion and activation.

Conclusions:

• iαβTs are a profoundly activated T-cell subset in PDA that inhibit tumor progression.
• iαβTs orchestrate crucial innate-adaptive immune crosstalk within the tumor microenvironment.
• iαβTs represent a significant and attractive therapeutic target for PDA immunotherapy.